The Rezon Bio Story: Interview with Dr. Adriana Kiedzierska-Mencfeld

At CDMO Live Europe 2026, Dr. Adriana Kiedzierska-Mencfeld, Chief Executive Officer of Rezon Bio, drew on 11 years of leading operations at Polpharma Biologics to explain why biosimilar developers must address cost strategy in process development, long before any product reaches market. https://pharmasource.global/content/p...